Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 0.482 |
Low | 0.482 |
Bid | -- |
Offer | -- |
Previous close | 0.482 |
Average volume | -- |
---|---|
Shares outstanding | 765.42m |
Free float | 607.28m |
P/E (TTM) | 5.68 |
Market cap | 979.73m HKD |
EPS (TTM) | 0.2253 HKD |
Data delayed at least 15 minutes, as of Apr 13 2022.
More ▼
Press releases
- Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer
- Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
- Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
- Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
- Harbour BioMed Announces 2024 Interim Results
More ▼